Prime Medicine
PRME · NASDAQ
$3.92+$0.09 (+2.35%)TodayMarket closed ·
Prev close $3.83
EPS: actual vs estimate
Beat the estimate in 2 of the last 8 quarters, by 15.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.2625 | -$0.24 | +8.6% |
| Q1 FY26 | -$0.2554 | -$0.28 | −9.6% |
| Q4 FY25 | -$0.2564 | -$0.26 | −1.4% |
| Q3 FY25 | -$0.2581 | -$0.32 | −24.0% |
| Q2 FY25 | -$0.3709 | -$0.41 | −10.5% |
| Q1 FY25 | -$0.3265 | -$0.40 | −22.5% |
| Q4 FY24 | -$0.3998 | -$0.31 | +22.5% |
| Q3 FY24 | -$0.4031 | -$0.44 | −9.2% |
Earnings calls
- Morgan Stanley 24th Annual Global Healthcare Conference
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Jefferies Global Healthcare Conference 2026
- The Citizens Life Sciences Conference 2026
- TD Cowen 46th Annual Health Care Conference
- 44th Annual J.P. Morgan Healthcare Conference
- Evercore 8th Annual Healthcare Conference
- Special Call - Prime Medicine, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.